CADL Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

KUPNO 2881 min ago

@ $11.45

Wydano: 17 geg. 2024 @ 18:14

Zwrot: 0.42%

Poprzedni sygnał: geg. 17 - 16:30

Poprzedni sygnał: Sprzedaż

Zwrot: -12.98 %

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):
Our systems believe the stock currently is overvalued by 0.69% compare to its pairs and should correct downwards.

Stats
Dzisiejszy wolumen	833 352
Średni wolumen	5.49M
Kapitalizacja rynkowa	342.06M
EPS	$0 ( 2024-05-09 )
Następna data zysków	( $0 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.78
ATR14	$2.10 (18.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-12	Schoch Charles	Sell	0	Common Stock
2024-01-12	Schoch Charles	Sell	0	Common Stock
2024-01-12	Schoch Charles	Sell	25 000	Stock Option (Right to Buy)
2024-01-12	Schoch Charles	Sell	39 498	Stock Option (Right to Buy)
2023-11-28	Tyagarajan Seshu	Sell	17 328	Common Stock

INSIDER POWER
76.86
Last 92 transactions
Buy: 8 106 969 \| Sell: 4 393 086

Korelacja (AI algo v.1.1b): Overvalued: -0.69% $11.47 paired level. (Algorytm śledzi zmiany najbardziej skorelowanych akcji w czasie rzeczywistym i natychmiast aktualizuje)

Wolumen Korelacja

Długi: -0.58 (weak negative)

Krótki: 0.74 (moderate)

Signal:(50) Neutral

Candel Therapeutics, Inc. Korelacja

10 Najbardziej pozytywne korelacje
SMTC	0.957
IZEA	0.953
MESO	0.952
QRHC	0.95
USAP	0.936
LE	0.934
THCP	0.93
LWAY	0.921
PAYS	0.92
LSAK	0.92

10 Najbardziej negatywne korelacje
LINK	-0.932
APDN	-0.918
MBIO	-0.906
HUGE	-0.903
ASNS	-0.901
WVVI	-0.9
VEEE	-0.895
ARAY	-0.894
INTZ	-0.893
ALLR	-0.891

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Candel Therapeutics, Inc. Korelacja - Waluta/Towar

-0.53
( weak negative )

-0.47
( neutral )

0.00
( neutral )

-0.66
( moderate negative )

0.13
( neutral )

0.71
( moderate )

Candel Therapeutics, Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-1.20M (0.00 %)
EPS:	$-1.310

FY	2023
Przychody:	$0
Zysk brutto:	$-1.20M (0.00 %)
EPS:	$-1.310

FY	2022
Przychody:	$125 000
Zysk brutto:	$-862 000 (-689.60 %)
EPS:	$-0.0994

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-1.934

Financial Reports:

No articles found.

Candel Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.